Approximately 200 people with certain rare CF mutations are now eligible for TRIKAFTA® TORONTO, ON – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that Health Canada has granted Marketing Authorization for the expanded… Read More
The wait is over! Roche Diagnostics Canada is pleased to announce the launch of the cobas® pulse system following Health Canada’s approval. This is the industry’s first professional blood glucose management solution… Read More
TORONTO, ON – LifeLabs has once again been named one of Canada’s Best Employers for Diversity by Forbes. This is the third consecutive year LifeLabs has received this recognition. Forbes and… Read More
Submissions are supported by the Phase 3 SELECT-GCA study demonstrating upadacitinib 15 mg with a 26-week steroid taper regimen achieved the primary endpoint of sustained remission from week 12 through… Read More
Approval based on FLAURA2 results, which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly nine months compared to standard of care MISSISSAUGA, ON – Health Canada has granted… Read More
